Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Psychiatry Research
|
February 7, 1997
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment
P D Hrdina, D Bakish, A Ravindran, et al.
International Clinical Psychopharmacology
|
March 1, 1997
Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy
D Bakish, C L Hooper, M D Thornton, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Preparatory brain potentials in major depressive disorder
V J Knott, Y D Lapierre, D de Lugt, et al.
Biological Psychiatry
|
July 27, 1999
Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims
L Du, G Faludi, M Palkovits, et al.
Pharmacoeconomics
|
November 4, 1995
Modelling the cost effectiveness of antidepressant treatment in primary care
D A Revicki, R E Brown, W Palmer, et al.
Psychopharmacology Bulletin
|
January 1, 1996
A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia
D Bakish, C L Hooper, M J Filteau, et al.
Psychological Medicine
|
May 20, 2008
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial
H Nicolini, D Bakish, H Duenas, et al.
Journal of Psychiatry & Neuroscience : JPN
|
October 1, 1992
A dose-finding study with remoxipride in the acute treatment of schizophrenic patients
Y D Lapierre, R Ancill, G Awad, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1993
Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder
D Bakish, Y D Lapierre, R Weinstein, et al.
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1990
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial
Y D Lapierre, N P Nair, G Chouinard, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Psychiatry Research
|
February 7, 1997
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment
P D Hrdina, D Bakish, A Ravindran, et al.
International Clinical Psychopharmacology
|
March 1, 1997
Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy
D Bakish, C L Hooper, M D Thornton, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Preparatory brain potentials in major depressive disorder
V J Knott, Y D Lapierre, D de Lugt, et al.
Biological Psychiatry
|
July 27, 1999
Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims
L Du, G Faludi, M Palkovits, et al.
Pharmacoeconomics
|
November 4, 1995
Modelling the cost effectiveness of antidepressant treatment in primary care
D A Revicki, R E Brown, W Palmer, et al.
Psychopharmacology Bulletin
|
January 1, 1996
A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia
D Bakish, C L Hooper, M J Filteau, et al.
Psychological Medicine
|
May 20, 2008
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial
H Nicolini, D Bakish, H Duenas, et al.
Journal of Psychiatry & Neuroscience : JPN
|
October 1, 1992
A dose-finding study with remoxipride in the acute treatment of schizophrenic patients
Y D Lapierre, R Ancill, G Awad, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1993
Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder
D Bakish, Y D Lapierre, R Weinstein, et al.
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1990
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial
Y D Lapierre, N P Nair, G Chouinard, et al.
Page
of 6